Xinlicheng, a company involved in pharmaceutical production and hospital management, has increased its registered capital from approximately 3.26 billion to 3.39 billion RMB. The company, established in September 2001 and led by Lin Yanglin, is jointly held by entities including Beijing Xinlicheng Health Industry Group Co., Ltd. This financial update was reported by 36Kr. AI
RANK_REASON Significant funding event for a company in the health industry. [lever_c_demoted from significant: ic=1 ai=0.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
